Action on Hearing Loss Logo
    Total results:
    Search
      Total results:

      Another step forward for gene therapy to treat hearing loss

      Researchers from Harvard Medical School in the US have recently used gene therapy to restore hearing in mice with a particular type of Usher syndrome. Carina Santos, our Translational Research Manager, tells us more about the work, and what it means for using gene therapy to treat hearing loss in people in the future.

      By: Carina Santos | 14 June 2017

      Genes are the master regulators of the characteristics that make us human, from the colour of our eyes to the number of toes we have in each foot, and our hearing is no exception!

      Over half of the cases of hearing loss in children worldwide are due to errors in genes called mutations. In fact, hearing loss acquired during ageing can also be influenced by our genetic make-up. Scientists around the world are working hard to develop gene therapies to correct the mutations that cause hearing loss. Two recent advances made by researchers at Harvard Medical School in the US have brought the prospect of gene therapies for hearing loss closer.

      Delivering genes to the cochlea (inner ear)

      The cochlea is the “hearing” part of the ear, where the sensory hair cells are located. These cells are responsible for translating sound into electrical signals that are sent to the brain, allowing us to hear. So, genetic mutations that affect the way these cells develop or work are likely to cause hearing loss. Scientists working on gene therapy to correct gene mutations in hair cells face the substantial challenge of how to deliver corrected genes to the large number of sensory hair cells in the cochlea, which is hard to access, as it is hidden behind the mastoid bone in our skull, the hardest bone in the body.

      The research, published this month in the scientific journal Nature Biotechnology, presents a new and highly efficient method of delivering corrected genes to 80-90% of sensory hair cells, using a new viral vector called Anc80L65. A viral vector is a harmless virus that scientists engineer to infect specific cells and deliver genes into them. Anc80L65 surpasses existing vectors because its high efficiency allows delivery of genes to different types of hair cells (called inner and outer hair cells), which have complementary and essential roles in the hearing process, as well as vestibular hair cells, which control balance and spatial orientation.

      How gene therapy restored hearing and balance in a mouse model

      Usher syndrome is a genetic disorder that causes profound deafness, blindness and balance disorders. It is responsible for 3-6% of childhood deafness. In a specific type of Usher syndrome, called type 1c, a gene called USH1C is defective, which results in hair cells failing to develop correctly, showing disorganised hair bundles (the hair-like structures on top of the cells that sense sound, and that give hair cells their name), and then dying. In this study, the researchers used mice which have the same mutation in their version of the USH1C gene, which is called Ush1c (naming conventions for genes mean that mouse genes are in lower case, while human genes are capitalised).

      By introducing a corrected version of the Ush1c gene into the inner ear of newborn mice, using the Anc80L65 vector, the researchers were able to restore the correct organization of the hair bundles and improve hearing in the mice by over a thousand-fold, relative to other existing inner ear gene therapy approaches. Along with hearing, balance was also restored in these mice. Although it’s still early days, gene therapy shows promise as a treatment to restore hearing and studies like these are helping to speed up access to these therapies by people.

      What’s next?

      The researchers are now focussed on perfecting the Anc80L65 vector, to limit the delivery of genes to hair cells only. Moreover, although the therapy showed the highest efficiency when used in newborn mice, the best therapeutic window for humans is still to be determined. Unlike in mice, human hearing is fully developed before birth and researchers need to assess if gene therapy would have to be given pre-natally, which would be a significant challenge, or if it will work if administered after birth.

      Find out more

      We depend on your donations so we can fund the best hearing and tinnitus research around the world. Donate today and help us continue our vital work into hearing treatments, so that people can live life to the full again.

      This research was published in the journal Nature Biotechnology.

      Full references:

      Pan B, Askew C, Galvin A, Heman-Ackah S, Asai Y, Indzhykulian AA, Jodelka FM, Hastings ML, Lentz JJ, Vandenberghe LH, Holt JR and Geleoc GS. Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1c. Nat Biotechnol. 2017 Mar; 35(3):264-272.

      Landegger LD, Pan B, Askew C, Wassmer SJ, Gluck SD, Galvin A, Taylor R, Forge A, Stankovic KM, Holt JR, Vandenberghe LH. A synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner ear. Nat Biotechnol. 2017 Mar; 35(3):280-284.

      You can find out more about our students, and the research we’re funding, in our biomedical research section.

      If you’re interested in finding out more about our research, sign up to receive our Soundbite e-newsletter. It’s a monthly email, filled with the latest news about hearing and tinnitus research.

      Recent Posts

      Protecting a lifeline in Parliament

      Over 700 of you have written to your MP, asking them to protect your local NHS audiology service. We held an event in Parliament on 26 June and MPs from constituencies across England dropped by to hear why hearing aids are a lifeline – and should be protected on the NHS.

      By: Jess McNulty
      28 June 2019

      Five steps to a more deaf-friendly workplace

      Is hearing loss affecting you at work? Do you sometimes feel stressed and isolated? Our Working for Change campaign aims to change attitudes in the workplace, so that people who are deaf or have hearing loss can thrive. Follow our five steps to a more deaf-friendly workplace. Then check out our products and services to help you focus on your job, not your hearing.

      By: Sally Bromham
      20 June 2019

      Our top five smoke alarms

      Would you hear a smoke alarm in the event of a fire? People with hearing loss may not be woken by an audible alarm. Plus, if you use hearing aids, you’re less likely to hear your smoke alarm when you take them out to sleep. Our smoke alarms are designed to work in a ‘system’, providing additional visual and vibrating alerts. Here’s a roundup of our top five smoke alarms to protect your home and family, with 10% off from 25 – 31 July 2019.

      By: Sally Bromham
      20 June 2019

      Bring your Dog to Work Day

      This 21 June is national ‘Bring Your Dog To Work Day’, but for people with assistance dogs, this is an everyday occurrence. James, one of our profoundly deaf supporters, was partnered with his hearing dog, Cracker, in October 2018 after applying for assistance through the UK based charity Hearing Dogs for Deaf People. Read about his story and his tips for working with deaf people.

      By: James
      19 June 2019